Profile for Canada Patent: 3132319
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 3132319
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 11,020,393 | Mar 2, 2040 | Strongbridge | RECORLEV | levoketoconazole |
| 11,278,547 | Mar 2, 2040 | Strongbridge | RECORLEV | levoketoconazole |
| 11,903,940 | Mar 2, 2040 | Strongbridge | RECORLEV | levoketoconazole |
| 12,377,096 | Mar 2, 2040 | Strongbridge | RECORLEV | levoketoconazole |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
